Navigation Links
Prostate Cancer Risk and Smoking
Date:6/30/2011

NEW YORK, June 30, 2011 /PRNewswire/ -- According to a recent study published in The Journal of the American Medical Association (JAMA), men with prostate cancer who smoke have increased prostate cancer-specific mortality compared to non-smokers with prostate cancer.  Smokers were also found to have a 61% increased risk of cancer recurrence after treatment. Interestingly, these increased mortality and recurrence rates were not seen in men who had quit smoking for at least 10 years. These men had similar risk profiles to those who never smoked.

(Photo:  http://photos.prnewswire.com/prnh/20110630/NY28444 )

In addition to what it tells us about the effects of smoking, this study also presents an important element of prevention into the general discussion of prostate cancer. While the major risk factors for the disease; age, race and family history, are well known, these factors are non-modifiable. Most doctors, therefore, recommend annual PSA screening in order to diagnose cancer as early as possible, especially for those who have high risk profiles. Unlike age, race and family history, however, smoking is a modifiable risk. According to this recent study, patients with prostate cancer who quit smoking for ten years will bring themselves back down to the risk category of those who never smoked at all.

Coincidentally, the FDA announced this week that new health warnings must be displayed on all cigarette packages and advertisements in the United States beginning no later than September 2012.  The new, larger warning labels show pictures of the effects smoking has on a person's health in graphic detail. With the ever-increasing medical evidence showing the harmful effects of smoking, there has never been a better time to quit.

For Dr. David Samadi, Vice Chairman, Department of Urology, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, the new information about smoking and prostate cancer makes all the difference. "Prostate cancer is a deadly disease, but it is not a death sentence. Men need to use all of the resources available to keep their risk as low as possible." He explained further, "Quitting smoking, as this study has shown, reduces your risk of dying from prostate cancer and of recurring once you've had treatment. And even if you've never smoked, you still need to get PSA testing annually over the age of 50 to stay in control of your health. If you have a family history of the disease, or of African American ancestry, you need to consider getting earlier PSA testing at 40."  

For those who are, unfortunately, diagnosed with prostate cancer, Dr. Samadi performs advanced, minimally-invasive robotic prostate surgery. Using his own SMART (Samadi Modified Advanced Robotic Technique) surgery, Dr. Samadi gives his patients excellent sexual and urinary quality of life after the prostate cancer treatment procedure with minimal risk of cancer recurrence. "The key is to lower your risk before diagnosis, and get PSA tested to ensure an early diagnosis. If you need to be treated, however, you'll want to choose a procedure that will eliminate the cancer while at the same time preserve your quality of life for years to come."

Dr. Samadi discusses men's health, prostate cancer prevention and prostate cancer risks associated with smoking on Fox News:

Smoking Linked to Increased Prostate Cancer Mortality‎

http://www.youtube.com/watch?v=Tzbfcp7dTsg

Prostate Cancer Prevention News - www.roboticoncology.com

http://www.youtube.com/watch?v=Pew6M7hckNY

Related Links: Smart-Surgery.com


'/>"/>
SOURCE RoboticOncology.com
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
2. Patented URINOZINC® Prostate Formula Now Available at GNC Stores
3. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
4. Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
5. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
6. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
7. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
8. Reportlinker Adds Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
9. Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
10. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
11. New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):